Clinical Trials on Neutropenia in Prematures

Total 11868 results

Hamad Medical Corporation
Merck Sharp & Dohme LLC

Withdrawn

CEFtolozane-Tazobactam for the Empiric Anti-bacterial Treatment of Neutropenic Fever in Hematology Patients (CEF-10)

Hematologic Cancer | Neutropenia, Febrile

Qatar
Istanbul University - Cerrahpasa (IUC)

Completed

EFFECTS OF AROMATHERAPY MASSAGE ON LACTATION IN NON-BREASTFEEDING MOTHERS WITH PREMATURE NEWBORNS IN NEONATAL INTENSIVE CARE UNIT

LACTATION IN MOTHERS WITH PREMATURE NEWBORNS

Turkey
Rigshospitalet, Denmark
Danish Cancer Society; Lundbeck Foundation; Børnecancerfonden

Completed

Host RNA Signature in Children With Cancer and Infection

Childhood Cancer | Infection | Neutropenia, Febrile

Denmark
Indonesia University

Completed

Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever

Leukemia | Pediatric Cancer | Neutropenia, Febrile | Antibiotic Reaction

Indonesia
BeyondSpring Pharmaceuticals Inc.
Covance; ICON plc

Completed

Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3 (Protective-1)

Chemotherapy-induced Neutropenia

China, Russian Federation, United States, Ukraine
Imperial College London
Imperial College Healthcare NHS Trust

Unknown

The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth

Preterm Birth | Preterm Labor | Preterm Premature Rupture of Membrane | Cervical Incompetence | Miscarriage in Second Trimester | Miscarriage in Third Trimester

United Kingdom
The Christie NHS Foundation Trust
University of Manchester; Isansys Lifecare LTD

Unknown

Remote Monitoring of Patients at Risk of Sepsis (REACT)

Sepsis | Cancer | Neutropenia, Febrile

United Kingdom
Sakarya University

Unknown

Analysis of the Effects of Oral Colostrum Administration in Premature Infants on the Breastfeeding (Oral colostrum)

Oral Colostrum Administration in Very Low Birth Weight Premature Infants

Turkey
Mansoura University Children Hospital

Completed

Light Protection of TPN and Oxidative Stress in Preterm Infants

Oxidative Stress in Preterm Infants

Egypt
Swedish Orphan Biovitrum

Completed

Efficacy and Safety of Bile Salt Stimulated Lipase (BSSL) as Replacement Therapy in Pasteurized Breast Milk for Preterm Infants

Replacement Therapy in Preterm Infants

France, Italy
Anhui Provincial Hospital

Unknown

Efficacy, Safety and Cost-effectiveness of PEG-rhG-CSF for Primary vs Secondary Prophylaxis

Chemotherapy-induced Neutropenia

China
Amgen

Completed

Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.

Chemotherapy-induced Febrile Neutropenia

France, Italy, Poland, Canada, Spain, Austria, Germany, Greece, Romania, Australia, Ireland
BeyondSpring Pharmaceuticals Inc.

Completed

Plinabulin iv Solution in Prevention of TAC Induced Neutropenia

Chemotherapy-induced Neutropenia

China, Ukraine
Jiangsu T-Mab Biopharma Co.,Ltd

Unknown

Study to Assess the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GW003 in Patients With Breast Cancer

Chemotherapy-induced Neutropenia

China
Gilead Sciences

Terminated

Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics

Febrile Neutropenia

Greece
Swedish Orphan Biovitrum

Completed

Efficacy and Safety of Bile Salt Stimulated Lipase (BSSL) as Replacement Therapy in Infant Formula for Preterm Infants

Replacement Therapy in Preterm Infants

Italy
University Hospital, Lille
Ministry of Health, France

Recruiting

DIStinguishing ChildrEn at Low Risk of Severe infectioN in Case of Febrile Neutropenia-7: Impact Study of a Clinical Decision Rule (DISCERN-FN7)

Neutropenia, Febrile

France
Hospital Infantil de Mexico Federico Gomez
Hospital Juarez de Mexico; Instituto Nacional de Pediatria

Completed

Safety and Efficacy of Ambulatory Versus In-hospital Antibiotic Treatment in Children With Febrile Neutropenia

Chemotherapy-Induced Febrile Neutropenia
All India Institute of Medical Sciences, New Delhi

Terminated

Early Stoppage Versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients With Febrile Neutropenia, Before Recovery of Counts: -DALFEN Study (DALFEN)

Pediatric Cancer | Neutropenia, Febrile

India
University Hospital, Grenoble
Laboratoire de Psychologie et NeuroCognition

Not yet recruiting

Face Perception and Impact of Surgical Masks in Preterm Infants (Premask)

Visual Preference With and Without Mask in Term Infant | Visual Preference With and Without Mask in Preterm Infant
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Neugranin in Breast Cancer Participants Receiving Doxorubicin/Docetaxel (NEUGR-003)

Chemotherapy-induced Neutropenia

Bulgaria, Romania, Russian Federation, Serbia, Ukraine
Centre Hospitalier Universitaire Dijon

Completed

Screening for Genes in Patients With Congenital Neutropenia (neutropenias)

Congenital Neutropenia

France
University of Rochester
Cubist Pharmaceuticals LLC

Terminated

Daptomycin Versus Placebo in Patients With Neutropenia and Fever

Febrile Neutropenia

United States
Prince of Songkla University
Merck Sharp & Dohme LLC

Completed

Comparison of the Pharmacodynamics of Imipenem in Patients With Febrile Neutropenia

Patients With Febrile Neutropenia

Thailand
Ankara City Hospital Bilkent

Recruiting

Comparison of Brain Volumes Measured by 2D USG and MRI

Central Nervous System Vulnerabilities in Preterm Infants

Turkey
IDION Inc.

Not yet recruiting

Remote Temperature Monitoring of Adult Subjects Undergoing Outpatient Stem Cell Transplant or CAR-T Cell Therapy

Febrile Neutropenia

United States
Assiut University

Recruiting

Risk Factors & Outcomes for Clinically Documented Infections in Pediatric Cancer Patients With Fever & Neutropenia

Febrile Neutropenia

Egypt
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel (NEUGR-002)

Chemotherapy-induced Neutropenia
University of Leeds
Philips Healthcare

Unknown

Profiling Neutrophil Counts in Patients on Chemotherapy

Neoplasms | Neutropenia | Febrile Neutropenia
Kjeld Schmiegelow

Recruiting

Early Termination of Empirical Antibiotics in Febrile Neutropenia in Children With Cancer

Pediatric Cancer | Neutropenia, Febrile

Denmark
Azienda Ospedaliero, Universitaria Pisana

Completed

Bed-side Ultrasound in Neutropenic Enterocolitis

Neutropenic Enterocolitis

Italy
Universitaire Ziekenhuizen KU Leuven
University Hospital, Ghent; Universitair Ziekenhuis Brussel; University Hospital... and other collaborators

Recruiting

Stopping Antibiotics After 3 Days for the Treatment of High-risk FEbrile Neutropenia (SAFE)

Neutropenia, Febrile

Belgium
Tianjin SinoBiotech Ltd.

Completed

Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patients

Chemotherapy-induced Neutropenia

China
Prolong Pharmaceuticals

Terminated

Randomized Phase 2, Dose-finding Efficacy, Safety Study of ANF-RHO™ Versus Neulasta® in Chemotherapy-Induced Neutropenia

Chemotherapy-induced Neutropenia

France, Netherlands
University of Utah
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

FDG-Positron Emission Tomography (PET)/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer Patients

Cancer

United States
Hadassah Medical Organization

Unknown

Garlic in Patients With Febrile Neutropenia

Neutropenia | Chemotherapy

Israel
Mylan Inc.
Mylan GmbH

Completed

Efficacy and Safety Study With MYL-1401H and Neulasta

Breast Neoplasms | Chemotherapy-Induced Febrile Neutropenia

Bulgaria, Georgia, Germany, Hungary, Poland, Ukraine
Assistance Publique - Hôpitaux de Paris

Terminated

Comparison of 2 Antifungal Treatment (Empirical Versus Pre-Empirical) Strategies in Prolonged Neutropenia

Malignant Hemopathy | Duration of Neutropenia Following Chemotherapy > 10 Days

France
University Hospital Muenster
Pfizer; Hoffmann-La Roche

Completed

Value of the LightCycler® SeptiFast Test MGRADE for the Pathogen Detection in Neutropenic Hematological Patients

Sepsis | Hematologic Diseases | Neutropenia | Febrile Neutropenia

Germany
Centre Hospitalier Universitaire, Amiens

Completed

Red Blood Cell Transfusion in Very Premature Infants and HAS 2014 Guideline (RBCPREM)

Practice Guideline of Erythrocyte Transfusion in Preterm Infant

France
Lady Hardinge Medical College

Completed

Role of Oral Sucrose in Reducing the Pain to Orogastric Tube Insertion in Preterm Neonates

Pain in Preterm Neonates

India
Cliniques universitaires Saint-Luc- Université...

Terminated

Predictive Value of ProCalcitonin for the Detection of Bacteraemia in Patients Presenting to the Emergency Department for Low Risk Chemo-induced Febrile Neutropenia (CALIF)

Febrile Neutropenia, Drug-Induced

Belgium
Memorial Health Services Research Council

Unknown

Dynamic Cervical Change: Prediction of Preterm Labor in Symptomatic Patients

Dynamic Cervical Change in Preterm Labor Patients

United States
Sanliurfa Mehmet Akif Inan Education and Research...

Completed

The Relationship Between Serum Gasdermin-D Levels and Pyroptosis and Preterm Labor

Gasdermin D Levels in Preterm Labor

Turkey
Boris Böll
Noscendo GmbH

Not yet recruiting

Next-Generation-Sequencing Approach to Neutropenic Sepsis (NEXUS)

Febrile Neutropenia
The University of Queensland

Recruiting

New Diagnostics in Neutropenia

Febrile Neutropenia

Australia
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Research Study To Test How Multiple Doses Of Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given by Subcutaneous Injection (SC) (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)

Neutropenia (Low White Blood Cell Count)

United States
Pfizer
Hospira, now a wholly owned subsidiary of Pfizer

Completed

A Research Study To Test How Filgrastim Hospira Works In The Body Of Healthy Study Subjects When Given By Subcutaneous Injection (Shot) Compared To An Already U.S.-Approved Drug Neupogen® (Amgen)

Neutropenia (Low White Blood Cell Count)

United States
Asociación para el Fomento de la Investigación...

Completed

Risk Assessment of Febrile Neutropenia and Grade 3-4 Neutropenia in Patients With Non-hematological Cancer Treated With Conventional Chemotherapy (NEURISK)

Non-hematologic Cancer

Spain
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

A Trial of HHPG-19K Injection and Auto-HHPG-19K Injection in Prevention of Chemotherapy-related Moderate to Severe Neutropenia of Patients With Nonmyeloid Malignancies

Patients With Nonmyeloid Malignancies Receiving Antineoplastic Therapy Based on Chemotherapy Regimens at Moderate to High Febrile Neutropenia (FN) Risk

China

Clinical Trials on Neutropenia in Prematures

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations